ストックスクリーナーアプリを入手
19.46
5.93%
1.09
プレマーケット:
19.53
0.07
+0.36%
Travere Therapeutics Inc (TVTX) 最新ニュース
Cantor Fitzgerald Predicts TVTX FY2025 Earnings - MarketBeat
What is Leerink Partnrs’ Estimate for TVTX FY2026 Earnings? - Defense World
Leerink Partnrs Issues Optimistic Estimate for TVTX Earnings - MarketBeat
Travere Therapeutics, Inc. (NASDAQ:TVTX) Shares Sold by Assenagon Asset Management S.A. - Defense World
Research Analysts Issue Forecasts for TVTX FY2024 Earnings - Defense World
HC Wainwright Issues Pessimistic Forecast for TVTX Earnings - MarketBeat
What is HC Wainwright’s Estimate for TVTX FY2029 Earnings? - Defense World
FY2029 Earnings Forecast for TVTX Issued By HC Wainwright - MarketBeat
Nephrotic Syndrome Market Set to Grow Substantially Through 2034, DelveInsight Projects | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squib - The Globe and Mail
Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $22.00 at HC Wainwright - MarketBeat
Alport Syndrome Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Eloxx Pharmac, Biogen, River 3 Renal Corp, Travere Therapeutics, Chinook Therapeutics - Barchart
Alport Syndrome Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail
Travere Therapeutics (NASDAQ:TVTX) Stock Price Down 4.2%Here's Why - MarketBeat
Travere Therapeutics Provides Corporate Update and 2025 Outlook - The Manila Times
Travere's FILSPARI Drives $50M Q4 Sales, European Expansion Gains Momentum with Multi-Country Launch - StockTitan
Travere Therapeutics (NASDAQ:TVTX) Coverage Initiated at Cantor Fitzgerald - Defense World
Wall Street Analysts Believe Travere (TVTX) Could Rally 42.56%: Here's is How to Trade - MSN
Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Insider Selling: Travere Therapeutics, Inc. (NASDAQ:TVTX) Insider Sells 2,066 Shares of Stock - MarketBeat
Travere therapeutics chief medical officer sells shares totaling $47,714 By Investing.com - Investing.com Canada
Travere therapeutics chief medical officer sells shares totaling $47,714 - Investing.com
Travere Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Travere Therapeutics (NASDAQ:TVTX) Trading Up 7.2%Here's Why - MarketBeat
High Growth Tech Stocks in the United States to Watch - Simply Wall St
Travere Therapeutics, Inc. (NASDAQ:TVTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Travere Therapeutics, Inc. (NASDAQ:TVTX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Geode Capital Management LLC Grows Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World
Travere Therapeutics, Inc. (NASDAQ:TVTX) Shares Acquired by Geode Capital Management LLC - MarketBeat
Travere Therapeutics, Inc. (NASDAQ:TVTX) CAO Sells $258,300.00 in Stock - MarketBeat
Travere therapeutics CAO Calvin Sandra sells $258,277 in stock By Investing.com - Investing.com Canada
Investing in Travere Therapeutics (NASDAQ:TVTX) a year ago would have delivered you a 82% gain - Yahoo Finance
Barclays PLC Sells 17,544 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World
State Street Corp Has $38.29 Million Stake in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy - The Eastern Progress Online
XTX Topco Ltd Cuts Stock Position in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat
Travere Therapeutics: Cautiously Bullish Based On Improving Revenue (NASDAQ:TVTX) - Seeking Alpha
Travere Therapeutics' SWOT analysis: stock poised for growth amid rare disease focus - Investing.com Canada
(TVTX) Investment Analysis - Stock Traders Daily
Y Intercept Hong Kong Ltd Lowers Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat
Fmr LLC Acquires 31,772 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World
The Manufacturers Life Insurance Company Purchases 17,931 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World
Travere Therapeutics' SWOT analysis: rare disease stock poised for growth By Investing.com - Investing.com Canada
TVTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Travere Therapeutics, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online
Charles Schwab Investment Management Inc. Sells 1,184 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World
Two Sigma Advisers LP Increases Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - MarketBeat
Travere Therapeutics, Inc. (NASDAQ:TVTX) Stock Holdings Lessened by Point72 Asia Singapore Pte. Ltd. - MarketBeat
4.81%
大文字化:
|
ボリューム (24 時間):